Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22058086 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Condition: Chronic Hepatitis C
Interventions: Drug: Silymarin;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.